首页|期刊导航|肿瘤学创新(英文)|Trastuzumab Deruxtecan for Human Epidermal Growth Factor Receptor 2-Low Breast Cancer With Cancer-Related Microangiopathic Hemolytic Anemia:A Case Report

Trastuzumab Deruxtecan for Human Epidermal Growth Factor Receptor 2-Low Breast Cancer With Cancer-Related Microangiopathic Hemolytic Anemia:A Case ReportOA

Trastuzumab Deruxtecan for Human Epidermal Growth Factor Receptor 2-Low Breast Cancer With Cancer-Related Microangiopathic Hemolytic Anemia:A Case Report

Mengyuan Li;Mao Ding;Yukun Hou;Xuening Duan;Yuanjia Cheng;Ling Xu

Department of Thyroid and Breast Surgery,Peking University First Hospital,Beijing,ChinaDepartment of Thyroid and Breast Surgery,Peking University First Hospital,Beijing,ChinaDepartment of Thyroid and Breast Surgery,Peking University First Hospital,Beijing,ChinaDepartment of Thyroid and Breast Surgery,Peking University First Hospital,Beijing,ChinaDepartment of Thyroid and Breast Surgery,Peking University First Hospital,Beijing,ChinaDepartment of Thyroid and Breast Surgery,Peking University First Hospital,Beijing,China

breast cancerHER2-lowmicroangiopathic hemolytic anemiatrastuzumab deruxtecan

breast cancerHER2-lowmicroangiopathic hemolytic anemiatrastuzumab deruxtecan

《肿瘤学创新(英文)》 2025 (5)

92-96,5

10.1002/cai2.70029

评论